Borage has long been known for its exceptional anti-inflammatory properties, thanks to its rich content of GLA (gamma-linolenic acid). However, dietary supplementation with borage seeds oil poses challenges, mainly related to its susceptibility to oxidation and peroxide reduction, compromising its effectiveness and shelf life.

In this context, IPS emerges as the ideal solution to overcome these obstacles through innovative coacervation microencapsulation technology.

The microencapsulation technology applied by IPS transforms borage seed oil into microcapsules with an oil content ranging from 80 to 90%, and a particle sizes between 100 and 600 μm.

This process enables the microencapsulation of the active ingredient within a polymeric membrane that protects it from oxidation and loss of efficacy due to peroxide degradation. Consequently, the microcapsules maintain the nutritional properties of borage seed oil, allowing its use in various solid oral formulations such as hard capsules, sachets, or orodispersible formulations.

The use of IPS microcapsules offers significant benefits for both manufacturers and consumers of dietary supplements. For manufacturers, it means being able to formulate products with improved stability and shelf life, reducing the risk of active ingredient degradation and ensuring consumers a superior quality product.

For consumers, it means access to more effective supplements, with increased GLA absorption and, consequently, a more pronounced impact on the body's inflammatory responses and overall health.

The innovation brought by IPS in the field of borage-based supplements opens up new prospects for the nutraceutical sector. With its borage seed oil microcapsules, IPS positions itself as a leader in providing advanced solutions for the production of dietary supplements, significantly contributing to the promotion of a healthy lifestyle and the improvement of quality of life.